Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 252Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Emay Pharmaceuticals

02 1Octavius Pharma Pvt. Ltd

03 2Acino Pharma

04 2Alembic Pharmaceuticals Limited

05 2Apotex Inc

06 2Ascent Innovative Medicines

07 1Aspire Lifesciences Pvt Ltd

08 2Kolmar Korea Co., Ltd.

09 2Laboratorio Eczane Pharma

10 4Murli Krishna Pharma

11 2Orchid Pharma

12 2PH HEALTH

13 4Pelcoat Formulations

14 2Smilax Laboratories Limited

15 4Sohan Healthcare

16 2TWi Pharmaceuticals

17 13Takeda Pharmaceutical

18 2Viatris

19 4World Medicine

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEmay Pharmaceuticals is a GMP-certified API manufacturing company.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name : Dexlansoprazole

Dosage Form : Pellets

Dosage Strength : 20%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Emay Pharmaceuticals

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name : Dexlansoprazole

Dosage Form : Pellets/Micro pellets for capsules

Dosage Strength : 17; 20; 22.5; 23%; %; %; %

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Octavius Pharma

03

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2025-11-12

Application Number : 219115

Regulatory Info : RX

Registration Country : USA

blank

04

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2025-11-12

Application Number : 219115

Regulatory Info : RX

Registration Country : USA

blank

05

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : Pellets

Dosage Strength : 17%W/W

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

06

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Dexlansoprazole

Brand Name : Decpranzole Tablet

Dosage Form : Tablet

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : South Korea

blank

07

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Dexlansoprazole

Brand Name : Decpranzole Tablet

Dosage Form : Tablet

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : South Korea

blank

08

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : DR CAPSULE

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic EU CTD

Registration Country : India

blank

09

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : DR CAPSULE

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic EU CTD

Registration Country : India

blank

10

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXILANT

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2009-01-30

Application Number : 22287

Regulatory Info : RX

Registration Country : USA

blank

11

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXILANT

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2009-01-30

Application Number : 22287

Regulatory Info : RX

Registration Country : USA

blank

12

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXILANT SOLUTAB

Dosage Form : TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2016-01-26

Application Number : 208056

Regulatory Info : DISCN

Registration Country : USA

blank

13

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2022-09-16

Application Number : 202666

Regulatory Info : RX

Registration Country : USA

blank

14

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2022-09-16

Application Number : 202666

Regulatory Info : RX

Registration Country : USA

blank

15

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2024-01-19

Application Number : 205205

Regulatory Info : RX

Registration Country : USA

blank

16

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2024-01-19

Application Number : 205205

Regulatory Info : RX

Registration Country : USA

blank

17

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 30MG

Packaging : 14 Or 28 Capsules

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Turkey

blank

18

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 60MG

Packaging : 14 Or 28 Capsules

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Turkey

blank

19

PH HEALTH

Country
Health 2.0 Conference
Not Confirmed
arrow

PH HEALTH

Country
arrow
Health 2.0 Conference
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2017-04-19

Application Number : 202294

Regulatory Info : RX

Registration Country : USA

blank

20

PH HEALTH

Country
Health 2.0 Conference
Not Confirmed
arrow

PH HEALTH

Country
arrow
Health 2.0 Conference
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2022-06-16

Application Number : 202294

Regulatory Info : RX

Registration Country : USA

blank